Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
Status:
Recruiting
Trial end date:
2023-04-10
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled phase I clinical study evaluating the
safety, tolerability, and pharmacokinetics of ASC11 plus ritonavir tablets in healthy
subjects and an open-label, cross-over study evaluating the effect of food on the
pharmacokinetics of ASC11 plus ritonavir tablets